Complete Filing Data
OneMeta Inc. reported Net Income Loss of -$4.60 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean OneMeta Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$4.6M | -$6.1M | -$1.3M | -$907.8K | -$1.1M | -$4.0M | -$5.4M |
| Cost of Revenue * | -$38.5K | -$143.4K | |||||
| Revenue * | $31.3K | $70.9K | $1.3K | $65.8K | $309.4K | ||
| Operating Expenses | $4.6M | $6.2M | $1.3M | $436.4K | $581.1K | $2.9M | $5.5M |
| General And Administrative Expense | $2.9M | $4.1M | $669.6K | $349.2K | $899.1K | $2.4M | $2.9M |
| Research And Development Expense | $896.9K | $757.3K | $157.7K | $84.0K | $2.5K | ||
| Operating Income Loss | -$4.5M | -$6.1M | -$1.3M | ||||
| Nonoperating Income Expense | -$73.9K | -$43.2K | -$33.4K | ||||
| Interest Expense | $43.2K | $33.4K | $2.5K | -$72.6K | -$56.5K | -$87.3K | |
| Income Loss From Continuing Operations | -$436.4K | -$581.1K | -$2.9M | -$5.4M | |||
| Interest Expense Nonoperating | $73.9K | $43.2K | |||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$907.8K | -$1.1M | -$4.0M | ||||
| Gross Profit | $27.3K | $166.0K | |||||
| Deferred Revenue Current | |||||||
| Income Loss From Continuing Operations Before Income Taxes Domestic | -$3.7M | -$5.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q1 2012 | Q3 2011 | Q1 2011 | Q4 2010 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$827.5K | -$467.5K | -$954.2K | -$935.4K | -$1.1M | -$937.1K | -$1.1M | -$3.5M | -$542.4K | -$213.4K | -$134.7K | -$395.8K | -$475.4K | -$538.8K | -$395.3K | -$355.2K | -$121.4K | -$95.2K | -$330.7K | -$532.7K | -$461.9K | -$906.8K | -$1.2M | ||
| Cost of Revenue * | $91.7K | -$9.5K | -$26.0K | -$50.1K | |||||||||||||||||||||
| Revenue * | $700.8K | $128.5K | $3.5K | $5.5K | $5.4K | $9.2K | $44.8K | $3.2K | $58.00 | $7.5K | $36.5K | $119.8K | |||||||||||||
| Operating Expenses | $988.5K | $1.1M | $904.3K | $1.1M | $935.6K | $1.1M | $3.5M | $535.7K | $204.7K | $460.8K | $513.2K | $384.5K | $109.8K | $99.5K | $45.1K | $240.3K | $376.2K | $406.3K | $818.5K | $1.2M | |||||
| General And Administrative Expense | $663.1K | $481.3K | $537.2K | $671.2K | $464.0K | $515.1K | $3.2M | $305.5K | $202.3K | $367.9K | $352.0K | $180.9K | $109.0K | $98.7K | $44.3K | $267.2K | $361.5K | $391.6K | $803.8K | $975.2K | |||||
| Research And Development Expense | $122.9K | $349.6K | $202.2K | $218.7K | $232.9K | $203.6K | $191.5K | $145.0K | $92.9K | $160.7K | $203.0K | ||||||||||||||
| Operating Income Loss | -$379.5K | -$929.5K | -$900.8K | -$1.1M | -$930.2K | -$1.0M | -$3.5M | -$532.5K | -$204.7K | ||||||||||||||||
| Nonoperating Income Expense | -$88.0K | -$24.7K | -$34.6K | -$19.2K | -$6.9K | -$11.0K | -$10.6K | -$9.9K | -$8.7K | ||||||||||||||||
| Interest Expense | $6.9K | $11.0K | $9.9K | $8.7K | -$13.8K | -$34.7K | -$14.3K | -$6.0K | -$4.4K | -$12.8K | -$11.2K | -$29.2K | -$53.6K | -$98.8K | -$4.9K | ||||||||||
| Income Loss From Continuing Operations | -$460.8K | -$513.2K | -$384.5K | -$109.8K | -$99.5K | -$45.1K | -$240.3K | -$376.2K | -$408.3K | -$808.0K | -$1.2M | ||||||||||||||
| Interest Expense Nonoperating | $88.0K | $24.7K | $34.6K | $19.2K | $6.9K | $11.0K | $10.6K | ||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$475.4K | -$538.8K | -$395.3K | -$355.2K | -$121.4K | -$95.2K | -$330.7K | -$532.7K | -$461.9K | ||||||||||||||||
| Gross Profit | $609.1K | $5.5K | -$2.1K | $10.5K | $69.7K | ||||||||||||||||||||
| Deferred Revenue Current | $405.0K | $520.0K | $610.0K | $700.0K | $16.0K | $19.5K | $16.0K | $3.6K | |||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Domestic | -$532.7K | -$461.9K | -$906.8K | -$1.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$3.6M | -$3.8M | -$1.3M | -$1.8M | -$837.8K | ||||
| Retained Earnings Accumulated Deficit | -$33.9M | -$27.8M | -$13.1M | -$12.0M | -$8.0M | ||||
| Liabilities Current | $1.0M | $1.0M | $1.4M | $1.8M | $997.4K | ||||
| Liabilities And Stockholders Equity | $1.1M | $1.5M | $31.7K | $54.9K | $159.6K | ||||
| Common Stock Value | $33.0K | $25.0K | $16.4K | $87.7K | $70.3K | ||||
| Assets | $1.1M | $1.5M | $31.7K | $54.9K | $159.6K | ||||
| Accounts Payable Current | $522.9K | $377.9K | $179.4K | $351.6K | $297.7K | ||||
| Assets Current | $1.1M | $400.7K | $25.4K | $26.3K | |||||
| Cash | $26.2K | $5.7K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $400.7K | ||||||||
| Liabilities | $1.0M | $1.0M | $1.4M | ||||||
| Cash And Cash Equivalents At Carrying Value | $26.2K | $5.7K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$914.1K | $729.2K | $393.4K | ||||||
| Accrued Liabilities Current | $37.1K | $109.5K | $24.0K | ||||||
| Accounts Receivable Net Current | $6.9K | $150.00 | |||||||
| Preferred Stock Value | $2.1K | $2.9K | $2.9K | ||||||
| Prepaid Expense And Other Assets Current | $6.8K | ||||||||
| Cash Period Increase Decrease | -$24.5K | $25.4K | -$26.2K | $20.4K | |||||
| Property Plant And Equipment Net | $6.3K | $113.6K | |||||||
| Loans Payable Current | $170.5K | $110.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$4.1M | -$3.4M | -$3.6M | -$2.7M | -$1.8M | -$1.2M | -$693.6K | $117.8K | -$355.1K | -$5.6M | -$3.9M | -$3.6M | -$3.9M | -$3.9M | -$2.1M | -$2.0M | -$1.9M | -$1.6M | -$1.5M | -$1.4M | -$1.3M | -$1.6M | -$1.1M | |||||
| Retained Earnings Accumulated Deficit | -$41.8M | -$40.9M | -$40.5M | -$39.5M | -$36.9M | -$35.9M | -$34.8M | -$32.9M | -$15.5M | -$15.0M | -$14.4M | -$14.1M | -$13.7M | -$13.2M | -$12.9M | -$12.2M | -$9.9M | |||||||||||
| Liabilities Current | $4.3M | $3.5M | $3.7M | $3.0M | $1.9M | $1.5M | $914.1K | $1.4M | $1.5M | $1.4M | $1.3M | $1.0M | $859.1K | $1.4M | $1.4M | $1.6M | $1.2M | |||||||||||
| Liabilities And Stockholders Equity | $230.1K | $124.3K | $179.2K | $314.8K | $46.6K | $339.2K | $220.5K | $1.0M | $20.2K | $5.3K | $3.4K | $4.0K | $4.0K | $6.9K | $63.7K | $40.3K | $72.1K | |||||||||||
| Common Stock Value | $38.9K | $38.9K | $37.8K | $37.8K | $34.0K | $33.7K | $33.1K | $30.6K | $117.5K | $54.4K | $31.9K | $31.9K | $635.6K | $385.6K | $327.9K | $284.7K | $83.0K | |||||||||||
| Assets | $230.1K | $124.3K | $179.2K | $314.8K | $46.6K | $339.2K | $220.5K | $1.0M | $20.2K | $5.3K | $3.4K | $4.0K | $4.0K | $6.9K | $63.7K | $40.3K | $72.1K | |||||||||||
| Accounts Payable Current | $885.3K | $697.4K | $767.8K | $586.3K | $583.2K | $476.3K | $417.7K | $472.6K | $276.1K | $283.5K | $179.9K | $168.4K | $178.7K | $169.5K | $215.2K | $334.2K | $343.2K | |||||||||||
| Assets Current | $230.1K | $124.3K | $179.2K | $314.8K | $46.6K | $339.2K | $220.5K | $225.4K | $18.6K | $3.2K | $780.00 | $870.00 | $40.00 | $1.4K | $52.9K | $85.00 | $150.00 | |||||||||||
| Cash | $18.6K | $3.2K | $780.00 | $870.00 | $40.00 | $130.00 | $1.4K | $25.4K | $52.9K | $85.00 | $42.5K | |||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $138.4K | $41.0K | $42.2K | $215.8K | $24.3K | $323.3K | $200.1K | $1.1M | $213.2K | $623.1K | ||||||||||||||||||
| Liabilities | $4.3M | $3.5M | $3.7M | $3.0M | $1.9M | $1.5M | $914.1K | $1.4M | $1.5M | $1.4M | $1.3M | $1.0M | $859.1K | |||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $18.6K | $3.2K | $780.00 | $870.00 | $40.00 | $130.00 | $1.4K | $25.4K | $52.9K | $85.00 | $42.5K | |||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$173.6K | -$929.8K | -$198.6K | |||||||||||||||||||||||||
| Accrued Liabilities Current | $113.8K | $65.4K | $61.1K | $18.0K | $4.0K | $4.0K | $10.2K | $28.9K | $57.4K | $105.6K | $79.2K | $51.6K | $15.2K | |||||||||||||||
| Accounts Receivable Net Current | $67.6K | $71.2K | $43.6K | $5.0K | $6.2K | $6.2K | $6.2K | $12.1K | $150.00 | |||||||||||||||||||
| Preferred Stock Value | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K | $2.1K | $2.9K | $2.9K | |||||||||||||||||||
| Prepaid Expense And Other Assets Current | $24.1K | $12.0K | $93.4K | $94.0K | $16.2K | $9.7K | $14.3K | |||||||||||||||||||||
| Cash Period Increase Decrease | -$90.00 | -$24.0K | $85.00 | -$26.2K | ||||||||||||||||||||||||
| Property Plant And Equipment Net | $1.5K | $2.1K | $2.6K | $3.1K | $3.9K | $5.5K | $40.2K | $54.9K | $69.6K | |||||||||||||||||||
| Loans Payable Current | $195.3K | $209.9K | $179.6K | $42.2K | $92.1K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $1.1M | $145.0K | $214.1K | $102.0K | $193.8K | $712.8K | |
| Proceeds From Issuance Of Common Stock | $725.6K | $3.1M | $1.3M | $420.0K | $855.3K | ||
| Net Cash Provided By Used In Operating Activities | -$2.6M | -$2.4M | -$722.1K | -$415.8K | -$657.7K | -$846.0K | -$1.5M |
| Net Cash Provided By Used In Financing Activities | $1.7M | $3.1M | $1.3M | $391.3K | $683.1K | $819.8K | $1.6M |
| Increase Decrease In Accrued Liabilities | -$100.1K | -$279.9K | $357.6K | -$8.2K | -$16.7K | $142.0K | $10.1K |
| Increase Decrease In Accounts Payable | $388.8K | $615.0K | -$54.9K | $2.6K | -$172.2K | $53.9K | $145.4K |
| Stock Issued During Period Value Share Based Compensation | $1.1M | $145.0K | $214.1K | ||||
| Increase Decrease In Accounts Receivable | -$1.9K | $6.9K | $150.00 | $17.0K | |||
| Proceeds From Related Party Debt | $72.0K | $351.3K | $280.5K | $244.1K | |||
| Increase Decrease In Deferred Revenue | $700.0K | -$3.6K | -$111.2K | ||||
| Proceeds From Loans | $40.0K | $446.1K | $183.0K | $328.3K | |||
| Increase Decrease In Prepaid Expenses Other | $87.2K | $6.8K | |||||
| Increase Decrease In Accrued Expenses | $18.0K | ||||||
| Net Cash Provided By Used In Investing Activities | -$210.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2022 | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $83.9K | $84.7K | $12.0K | $92.5K | $120.0K | ||||||||
| Proceeds From Issuance Of Common Stock | $300.0K | $465.6K | $465.6K | $35.0K | $175.0K | $102.5K | |||||||
| Net Cash Provided By Used In Operating Activities | -$616.6K | -$964.8K | -$373.6K | -$298.6K | -$54.2K | -$191.1K | -$502.5K | ||||||
| Net Cash Provided By Used In Financing Activities | $443.0K | $35.0K | $175.0K | $298.5K | $30.2K | $191.1K | $476.4K | ||||||
| Increase Decrease In Accrued Liabilities | $74.7K | -$107.6K | $11.2K | -$9.5K | $12.8K | -$23.9K | -$13.3K | ||||||
| Increase Decrease In Accounts Payable | $264.0K | -$15.8K | $46.0K | $11.5K | -$9.9K | -$17.5K | $15.5K | ||||||
| Stock Issued During Period Value Share Based Compensation | $83.9K | $94.9K | $92.3K | $84.7K | $54.2K | $79.7K | $12.0K | $214.1K | |||||
| Increase Decrease In Accounts Receivable | $38.6K | -$775.00 | |||||||||||
| Proceeds From Related Party Debt | $298.5K | $30.2K | |||||||||||
| Increase Decrease In Deferred Revenue | -$90.0K | $16.0K | -$3.6K | ||||||||||
| Proceeds From Loans | $223.1K | $42.5K | |||||||||||
| Increase Decrease In Prepaid Expenses Other | -$591.00 | $7.4K | |||||||||||
| Increase Decrease In Accrued Expenses | $43.0K | ||||||||||||
| Net Cash Provided By Used In Investing Activities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.17 | -$0.22 | -$0.06 | -$0.03 | -$0.08 | -$0.05 | -$0.08 |
| Common Stock Shares Outstanding | 33.0M | 25.0M | 16.4M | 87.7M | 70.3M | ||
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 25.0M | 25.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Issued | 33.0M | 25.0M | 16.4M | 87.7M | 70.3M | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 1.50B | 300.0M | 300.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Earnings Per Share Basic | $-0.17 | $-0.22 | $-0.06 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 33.9M | 28.5M | 22.2M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 33.9M | 28.5M | 22.2M | ||||
| Preferred Stock Shares Issued | 2.1M | 2.9M | 2.9M | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 27.9M | 13.9M | 78.0M | ||||
| Additional Shares Issued For Prior Year Software Acquisition | 2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q1 2012 | Q3 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.01 | -$0.03 | -$0.03 | -$0.03 | -$0.03 | -$0.03 | -$0.12 | -$0.02 | -$0.01 | -$0.08 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.00 | -$0.00 | -$0.01 | -$0.01 | -$0.02 | |||
| Common Stock Shares Outstanding | 38.9M | 38.9M | 38.8M | 37.8M | 34.0M | 33.7M | 33.1M | 30.6M | 117.5M | 54.3M | 31.9M | 31.9M | 635.6M | 19.3M | 327.9M | 284.7M | 83.0M | ||||||
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Common Stock Shares Issued | 38.9M | 38.9M | 38.8M | 37.8M | 34.0M | 33.7M | 33.1M | 30.6M | 117.5M | 54.3M | 31.9M | 31.9M | 635.6M | 385.6M | 327.9M | 284.7M | 83.0M | ||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 1.50B | 1.50B | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 300.0M | 300.0M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Earnings Per Share Basic | $-0.01 | $-0.03 | $-0.03 | $-0.03 | $-0.03 | $-0.03 | $-0.12 | $-0.02 | $-0.01 | ||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 38.9M | 37.8M | 33.7M | 33.2M | 33.0M | 30.2M | 28.2M | 25.0M | 22.5M | ||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 38.9M | 37.8M | 33.7M | 33.2M | 33.0M | 30.2M | 28.2M | 25.0M | 22.5M | ||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | 2.9M | 2.9M | ||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 61.4M | 44.4M | 31.9M | 25.8M | 24.3M | 17.5M | 326.9M | 154.6M | 77.2M | 71.0M | |||||||||||||
| Additional Shares Issued For Prior Year Software Acquisition |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $34.0M | $24.2M | $11.8M | $10.1M | $7.1M | ||
| Stock Issued During Period Value New Issues | $725.6K | $3.1M | $1.3M | ||||
| Marketing And Advertising Expense | $92.7K | $192.7K | $49.8K | ||||
| Legal And Professional Fees | $626.0K | $464.9K | $434.5K | ||||
| Depreciation And Amortization | $3.2K | $48.6K | $58.7K | $762.9K | |||
| Stock Issued During Period Shares New Issues | 969.5K | 6.0M | 3.6M | ||||
| Expenses Paid | $325.4K | $470.0K | $113.4K | ||||
| Adjustments To Additional Paid In Capital Imputed Interest | |||||||
| Adjustment For Amortization | $391.8K | $98.0K | -$285.8K | -$537.6K | -$1.0M | ||
| Other Depreciation And Amortization | $285.8K | $537.6K | $1.0M | ||||
| Other Operating Income Expense Net | -$471.4K | -$561.7K | -$1.1M | ||||
| Imputed Interest | $5.6K | $6.7K | $6.7K | ||||
| Contributed Capital | $4.4K | $351.5K | |||||
| Adjustments To Additional Paid In Capital Contributed Capital | $4.4K | $351.5K | |||||
| Imputed Interests | $5.6K | $6.7K | $6.7K | ||||
| Restricted Stock Expense | $385.8K | $1.2M | $515.6K | ||||
| Adjustments To Additional Paid In Capital Other |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q1 2012 | Q3 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $37.6M | $37.5M | $36.9M | $36.8M | $35.0M | $34.7M | $34.1M | $32.5M | $13.2M | $12.5M | $12.4M | $12.4M | $11.6M | $11.5M | $11.2M | $10.3M | $8.7M | ||||||||
| Stock Issued During Period Value New Issues | $475.0K | $225.0K | $465.6K | $35.0K | $175.0K | $1.0M | $175.0K | $532.0K | $85.0K | $100.0K | |||||||||||||||
| Marketing And Advertising Expense | $7.8K | $8.7K | $25.3K | $20.4K | $33.0K | $71.3K | $29.2K | $60.6K | $2.4K | ||||||||||||||||
| Legal And Professional Fees | $194.8K | $218.4K | $139.6K | $146.5K | $205.7K | $265.9K | $97.3K | $24.6K | |||||||||||||||||
| Depreciation And Amortization | $531.00 | $531.00 | $531.00 | $790.00 | $790.00 | $790.00 | $14.7K | $14.7K | $14.7K | $14.7K | $248.8K | ||||||||||||||
| Stock Issued During Period Shares New Issues | 582.0K | 582.0K | 87.5K | ||||||||||||||||||||||
| Expenses Paid | $82.5K | $89.4K | $78.0K | ||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Imputed Interest | $1.7K | $1.7K | $1.7K | $1.7K | $1.7K | $1.7K | |||||||||||||||||||
| Adjustment For Amortization | $98.0K | -$70.7K | -$37.3K | -$79.3K | -$127.3K | -$53.6K | |||||||||||||||||||
| Other Depreciation And Amortization | -$823.00 | $357.00 | $1.5K | -$70.7K | $18.4K | $37.3K | -$79.3K | $127.3K | -$53.6K | $98.8K | |||||||||||||||
| Other Operating Income Expense Net | -$14.6K | -$25.6K | -$10.9K | -$245.4K | -$21.9K | -$50.1K | -$90.5K | -$156.5K | -$53.6K | ||||||||||||||||
| Imputed Interest | $1.7K | $1.7K | |||||||||||||||||||||||
| Contributed Capital | $4.4K | ||||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Contributed Capital | $4.4K | ||||||||||||||||||||||||
| Imputed Interests | $1.7K | ||||||||||||||||||||||||
| Restricted Stock Expense | $241.1K | $172.1K | |||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Other | $40.9K | $66.4K | $1.7K | $1.7K | $1.7K |
Most recent annual filing with the SEC: March 6, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.